Skip to main content
Toggle navigation
Login
Search
Home
Final Program
Full Schedule
Home
Full Schedule
All Days
Wed, Oct 16
Thu, Oct 17
Fri, Oct 18
Full Schedule
Type here to filter the list
Friday, October 18, 2024
7:30 AM – 8:30 AM
ET
Continental Breakfast
7:30 AM – 8:30 AM
ET
Continental Breakfast
Location: Grand Ballroom VI, Level 3
7:30 AM – 5:30 PM
ET
ASAM Registration Open
7:30 AM – 5:30 PM
ET
ASAM Registration Open
Location: Grand Foyer West, Level 3
8:30 AM – 8:45 AM
ET
Opening Remarks
8:30 AM – 8:45 AM
ET
Opening Remarks
Location: Grand Ballroom I-V, Level 3
8:45 AM – 10:30 AM
ET
Alcohol
8:45 AM – 8:50 AM
ET
Session Introduction
Location: Grand Ballroom I-V, Level 3
Moderator:
Yara Moustafa, MD, PhD
– Lake Correctional Institution/NSU College of Osteopathic Medicine
8:50 AM – 9:10 AM
ET
Spironolactone in Alcohol Addiction: A Translational Approach
Location: Grand Ballroom I-V, Level 3
Presenter:
Lorenzo Leggio, MD, PhD, MSc
– NIDA/NIAAA, NIH
9:10 AM – 9:30 AM
ET
Psychedelics for the Treatment of Alcohol Use Disorder
Location: Grand Ballroom I-V, Level 3
Presenter:
Michael P. Bogenschutz, MD
– NYU Langone Center for Psychedelic Medicine
9:30 AM – 9:50 AM
ET
Repurposing the Glucagon-Like Peptide-1 Receptor Agonist Semaglutide to Treat Alcohol Use Disorder
Location: Grand Ballroom I-V, Level 3
Presenter:
Stephanie T. Weiss, MD, PhD
– National Institute on Drug Abuse Intramural Research Program
9:50 AM – 10:10 AM
ET
Technology-Assisted Approaches to Facilitate Remotely Delivered Alcohol Use Disorder Treatment
Location: Grand Ballroom I-V, Level 3
Presenter:
Mikhail N. Koffarnus, PhD
– University of Kentucky
10:10 AM – 10:30 AM
ET
Session Panel
Location: Grand Ballroom I-V, Level 3
10:30 AM – 10:45 AM
ET
Refreshment Break
10:30 AM – 10:45 AM
ET
Refreshment Break
Location: Grand Foyer West, Level 3
10:45 AM – 12:30 PM
ET
Nicotine
10:45 AM – 10:50 AM
ET
Session Introduction
Location: Grand Ballroom I-V, Level 3
Moderator:
Michael F. Weaver, MD, DFASAM
– Center for Neurobehavioral Research on Addiction
10:50 AM – 11:10 AM
ET
Adaptive Trials for Tobacco Cessation
Location: Grand Ballroom I-V, Level 3
Presenter:
Gina R. Kruse, MD, MS, MPH
– University of Colorado School of Medicine
11:10 AM – 11:30 AM
ET
GLP-1 Agonists for the Treatment of Nicotine Dependence and Post-Cessation Weight Management: The Skinny on Novel Anti-Obesity Medications
Location: Grand Ballroom I-V, Level 3
Presenter:
Luba Yammine, PhD
– UTHealth Houston McGovern Medical School
11:30 AM – 11:50 AM
ET
Tobacco Use among Older Adults: A Forgotten Population
Location: Grand Ballroom I-V, Level 3
Presenter:
Annie A. Kleykamp, PhD, MA
– University of Maryland School of Medicine
11:50 AM – 12:10 PM
ET
Novel and Emerging Interventions for Patients Unwilling to Quit
Location: Grand Ballroom I-V, Level 3
Presenter:
Peter Selby, MBBS, CCFP(AM), FCFP, MHSc, DFASAM
– Centre for Addiction and Mental Health
12:10 PM – 12:30 PM
ET
Session Panel
Location: Grand Ballroom I-V, Level 3
12:30 PM – 1:30 PM
ET
Lunch Break
12:30 PM – 1:30 PM
ET
Lunch Break
Location: Grand Ballroom VI, Level 3
1:30 PM – 2:30 PM
ET
Federal Agency Session
1:30 PM – 2:30 PM
ET
Federal Agency Session
Location: Grand Ballroom I-V, Level 3
Presenter:
Wilson M. Compton, MD, MPE
– National Institute on Drug Abuse
Presenter:
George F. Koob, PhD
– NIH
Presenter:
Yngvild K. Olsen, MD, MPH, DFASAM
– Substance Abuse and Mental Health Services Administration (SAMHSA)
2:30 PM – 3:30 PM
ET
Cannabis
2:30 PM – 2:35 PM
ET
Session Introduction
Location: Grand Ballroom I-V, Level 3
Moderator:
Michael F. Weaver, MD, DFASAM
– Center for Neurobehavioral Research on Addiction
2:35 PM – 2:55 PM
ET
Using Human Laboratory Studies to Characterize the Effects of Novel Cannabis Products, Formulations, and Routes of Administration
Location: Grand Ballroom I-V, Level 3
Presenter:
Tory R. Spindle, PhD
– Johns Hopkins University
2:55 PM – 3:15 PM
ET
How Laboratory Science Can Inform Cannabis Use Prevention, Treatment, and Regulation
Location: Grand Ballroom I-V, Level 3
Presenter:
Justin C. Strickland, PhD
– Johns Hopkins University School of Medicine
3:15 PM – 3:30 PM
ET
Session Panel
Location: Grand Ballroom I-V, Level 3
3:30 PM – 3:45 PM
ET
Refreshment Break
3:30 PM – 3:45 PM
ET
Refreshment Break
Location: Grand Foyer West, Level 3
3:45 PM – 5:30 PM
ET
Stimulants
3:45 PM – 3:50 PM
ET
Session Introduction
Location: Grand Ballroom I-V, Level 3
Moderator:
Yara Moustafa, MD, PhD
– Lake Correctional Institution/NSU College of Osteopathic Medicine
3:50 PM – 4:10 PM
ET
Novel Approaches to the Prevention and Treatment of Stimulant Use Disorders
Location: Grand Ballroom I-V, Level 3
Presenter:
Brian Hurley, MD, MBA, FAPA, DFASAM
– Los Angeles County Department of Public Health
4:10 PM – 4:30 PM
ET
Mosaic Approaches to Understanding ADHD and Stimulant Use Disorders
Location: Grand Ballroom I-V, Level 3
Presenter:
Vita V. McCabe, MD
– University of Michigan, Ann Arbor
4:30 PM – 4:50 PM
ET
BEAT Meth: New Findings for Advancing Methamphetamine Addiction Treatment
Location: Grand Ballroom I-V, Level 3
Presenter:
Alia A. Al-Tayyib, PhD
– Denver Health
4:50 PM – 5:10 PM
ET
Development of Dual-Acting Sigma and Dopamine Transporter Inhibitors as Potential Pharmacotherapy for Stimulant Use Disorders
Location: Grand Ballroom I-V, Level 3
Presenter:
Christopher R. McCurdy, BSPh, PhD, FAAPS
– University of Florida
5:10 PM – 5:30 PM
ET
Session Panel
Location: Grand Ballroom I-V, Level 3
5:30 PM – 5:45 PM
ET
Final Wrap-Up
5:30 PM – 5:45 PM
ET
Closing Remarks
Location: Grand Ballroom I-V, Level 3
Presenter:
Jarratt D. Pytell, MD, MHS
– Johns Hopkins School of Medicine
